New integration option aggregating bi-directional interfacing between multiple devices across multiple modalities.

Twin Cities, MN — October 6th, 2022

Biomedix announced the availability of a bi-directional interface designed to support the automated integration between their Biomedix Xchange point-of-care diagnostic platform, with customer and stakeholder EMRs, CRMs, and other systems of record. 

“Making member data available to the right stakeholder, at the right time is critical to delivering true value-based care,” said John Romans, CEO of Biomedix. “Our new Biomedix Xchange platform enables the secure delivery of relevant and appropriate point-of-care data to the various stakeholders within value-based care organizations.” 

“Oftentimes, organizations utilizing multiple diagnostic devices at multiple points of care need to develop a separate interface for each device,” said Chris Trygstad, Marketing and Network Director at Biomedix. “Leveraging Biomedix Xchange enables the aggregation of data from multiple devices covering multiple modalities into a single cloud-based service platform, so that IT integration teams only need to setup one interface, and then add on modalities and devices without having to undergo additional interfacing projects.” 

About Biomedix 

Biomedix is a provider of point-of-care diagnostic solutions for delivering value-based care. Biomedix Xchange is a population health solution that securely centralizes data for analyzing population health across multiple chronic conditions. For more information, visit Biomedix.com. 

About PADnet & PADnet Xpress 

Biomedix is the maker of PADnet, the market leader in front-line diagnostics for peripheral vascular disease. PADnet is the only diagnostic device that can support the identification of PAD and chronic venous insufficiency (CVI) through a unique collaborative care model. PADnet Xpress represents the latest technology for quick and accurate PAD detection, custom-designed for value-based care, including Medicare Advantage Organizations (MAOs).